Literature DB >> 15717238

[Posttraumatic elbow stiffness: planning and technical aspects of arthrolysis].

D Pennig1, K Mader, T Gausepohl.   

Abstract

Posttraumatic limitation of range of motion in the elbow joint may be of extraarticular, intraarticular or mixed origin. If conservative management fails to improve elbow motion, arthroscopic arthrolysis, open arthrolysis and distraction arthroplasty are available as therapeutic options. Joint distraction for gradual lengthening of shortened ligaments and capsules is used to disimpact the humero-ulnar articular surface. Under distraction fixator controlled mobilization is carried out. The use of transarticular external fixation is particularly helpful in cases of subluxation in order to restore joint congruity and facilitate postoperative physiotherapy. The postoperative management plays an important role in achieving the therapeutic goal.

Entities:  

Mesh:

Year:  2005        PMID: 15717238     DOI: 10.1055/s-2004-836241

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  5 in total

1.  [Results of open arthrolysis for extrinsic elbow stiffness via radial access. Indications and limits of the procedure].

Authors:  D Schorn; J Steinbeck
Journal:  Orthopade       Date:  2011-04       Impact factor: 1.087

2.  [Open arthrolysis of elbow stiffness].

Authors:  B Ulmar; A Eschler; T Mittlmeier
Journal:  Unfallchirurg       Date:  2012-08       Impact factor: 1.000

3.  [Distraction arthrodiatasis in elbow stiffness].

Authors:  Dietmar Pennig; Konrad Mader; Steffen Heck
Journal:  Oper Orthop Traumatol       Date:  2009-12       Impact factor: 1.154

4.  [Arthroscopic arthrolysis of the elbow joint].

Authors:  A Achtnich; P Forkel; S Metzlaff; W Petersen
Journal:  Oper Orthop Traumatol       Date:  2013-04       Impact factor: 1.154

5.  [Open arthrolysis of posttraumatic elbow stiffness].

Authors:  K Kolb; H Koller; U Holz; W Kolb; C Windisch; E Markgraf; P A Grützner
Journal:  Unfallchirurg       Date:  2008-05       Impact factor: 1.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.